ATA310274A - Verfahren zur herstellung des neuen fortimicin b - Google Patents

Verfahren zur herstellung des neuen fortimicin b

Info

Publication number
ATA310274A
ATA310274A AT743102A AT310274A ATA310274A AT A310274 A ATA310274 A AT A310274A AT 743102 A AT743102 A AT 743102A AT 310274 A AT310274 A AT 310274A AT A310274 A ATA310274 A AT A310274A
Authority
AT
Austria
Prior art keywords
manufacturing
fortimicin
new
new fortimicin
Prior art date
Application number
AT743102A
Other languages
English (en)
Other versions
AT329180B (de
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of ATA310274A publication Critical patent/ATA310274A/de
Application granted granted Critical
Publication of AT329180B publication Critical patent/AT329180B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT310274A 1973-04-17 1974-04-12 Verfahren zur herstellung des neuen fortimicin b AT329180B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP48042696A JPS5246311B2 (de) 1973-04-17 1973-04-17

Publications (2)

Publication Number Publication Date
ATA310274A true ATA310274A (de) 1975-07-15
AT329180B AT329180B (de) 1976-04-26

Family

ID=12643199

Family Applications (1)

Application Number Title Priority Date Filing Date
AT310274A AT329180B (de) 1973-04-17 1974-04-12 Verfahren zur herstellung des neuen fortimicin b

Country Status (17)

Country Link
JP (1) JPS5246311B2 (de)
AR (1) AR201860A1 (de)
AT (1) AT329180B (de)
BE (1) BE813772A (de)
CA (1) CA1025384A (de)
CH (1) CH590925A5 (de)
DE (1) DE2418349C3 (de)
DK (1) DK137864B (de)
ES (1) ES425440A1 (de)
FR (1) FR2226159B1 (de)
GB (1) GB1462805A (de)
IN (1) IN139126B (de)
NL (1) NL157655B (de)
NO (1) NO139864C (de)
PH (1) PH12923A (de)
SE (1) SE420214B (de)
ZA (1) ZA742107B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5218888A (en) * 1975-08-01 1977-02-12 Kyowa Hakko Kogyo Co Ltd Preparation of fortimicin c
JPS6011718B2 (ja) * 1976-09-23 1985-03-27 協和醗酵工業株式会社 新規なホ−テイマイシンbの誘導体およびその製法
US4091032A (en) * 1976-09-23 1978-05-23 Abbott Laboratories 4-N-acylfortimicin B derivatives and the chemical conversion of fortimicin B to fortimicin A
JPS53141244A (en) * 1977-05-11 1978-12-08 Kyowa Hakko Kogyo Co Ltd Novel hortemycin derivatives
US4219643A (en) * 1979-03-29 1980-08-26 Abbott Laboratories Fortimicin AN
CN109897862B (zh) * 2019-02-03 2020-10-02 浙江海正药业股份有限公司 庆大霉素b生产菌及其制备方法和应用

Also Published As

Publication number Publication date
CA1025384A (en) 1978-01-31
NL7405105A (de) 1974-10-21
DK137864C (de) 1978-10-23
JPS5246311B2 (de) 1977-11-24
DE2418349A1 (de) 1974-11-07
AR201860A1 (es) 1975-04-24
SE420214B (sv) 1981-09-21
NL157655B (nl) 1978-08-15
FR2226159A1 (de) 1974-11-15
ES425440A1 (es) 1976-06-01
DE2418349B2 (de) 1979-08-16
JPS49126892A (de) 1974-12-04
AU6768374A (en) 1975-10-09
CH590925A5 (de) 1977-08-31
GB1462805A (en) 1977-01-26
IN139126B (de) 1976-05-08
AT329180B (de) 1976-04-26
NO139864C (no) 1979-05-23
BE813772A (fr) 1974-10-16
FR2226159B1 (de) 1977-07-01
DE2418349C3 (de) 1980-04-24
NO741300L (no) 1974-10-18
ZA742107B (en) 1975-04-30
PH12923A (en) 1979-10-10
DK137864B (da) 1978-05-22
NO139864B (no) 1979-02-12

Similar Documents

Publication Publication Date Title
AT347611B (de) Verfahren zur herstellung von neuen d-homo-20- ketopregnanen
AT336555B (de) Verfahren zur herstellung von neuen athoxylierten hydroxyathern
AT329045B (de) Verfahren zur herstellung von neuen, basisch substituierten indanderivaten
AT325605B (de) Verfahren zur herstellung von neuen alpha-phenylindolderivaten
AT333300B (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
AT330955B (de) Verfahren zur herstellung von neuen beta-lactamen
AT329180B (de) Verfahren zur herstellung des neuen fortimicin b
AT333990B (de) Verfahren zur herstellung des neuen 17beta-hydroxy-16,16-dimethylostr-4-en-3-ons
AT323125B (de) Verfahren zur herstellung des neuen kalzium-lysinochlorids
AT331797B (de) Verfahren zur herstellung des neuen 1,3-bis- (beta-athylhexyl)-5-amino-5-methyl-hexahydropyrimidin-pyridin-3-carboxylats
AT326103B (de) Verfahren zur herstellung des neuen 1-dodecylaminomethyl-2-amino-cyclopentans
AT328452B (de) Verfahren zur herstellung von neuen 1,4-dihydrochinolinen
AT331805B (de) Verfahren zur herstellung von neuen triazinobenzimidazolen
AT323189B (de) Verfahren zur herstellung von neuen lactamen
AT333740B (de) Verfahren zur herstellung von neuen indanderivaten
AT333958B (de) Verfahren zur herstellung von neuen cephalosporinantibiotica
ATA562274A (de) Verfahren zur herstellung von neuen bis-triazinobenzimidazolen
ATA878175A (de) Verfahren zur herstellung des neuen 2-athoxy-4-amino-5-fluorpyrimidins
AT340594B (de) Verfahren zur herstellung des neuen alfa-carbathoxy-1-adamantylmethylpenicillins
AT339880B (de) Verfahren zur herstellung von neuen bicycloalkanderivaten
AT325594B (de) Verfahren zur herstellung des neuen 1-octylaminomethyl-2-octylamino-cyclopentans
ATA243775A (de) Verfahren zur herstellung von neuen 1-acyl-3- biphenylyl-propanonen
ATA896174A (de) Verfahren zur herstellung von neuen triazinobenzimidazolen
ATA543975A (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen
ATA904574A (de) Verfahren zur herstellung von neuen hydroxyalkylxanthinen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee